Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide for clozapine- and olanzapine-induced weight gain in schizophrenia
NCT00690235Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2007
- Primary completion
- Aug 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of pramlintide in obesity, sponsored by UT Southwestern Medical Center. Started Nov 2007; status: completed.
02
Drugs
pramlintide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00690235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690235.